Cloning, deletion and complementation of catB

CY Chao Yu
NW Nu Wang
MW Maosen Wu
FT Fang Tian
HC Huamin Chen
FY Fenghuan Yang
XY Xiaochen Yuan
CY Ching-Hong Yang
CH Chenyang He
request Request a Protocol
ask Ask a question
Favorite

The full length (1,524 bp) of catB including ribosome binding site (gene ID: PXO_02830) was amplified by polymerase chain reaction (PCR) using the primer pairs P1/P2 (Additional file 5: Table S2). A right fragment (489 bp) and a left one (582 bp) were amplified by PCR using the primer pairs catBrF/catBrR and catBlF/catBlR (Additional file 5: Table S2), respectively. The PCR fragments were gel purified and cloned to the middle vector pMD18-T (Takara, Tokyo, Japan), resulting in constructs pMDcatB, pMDcatBr, and pMDcatBl, which were verified by DNA sequencing (Beijing Genomics Institute, Beijing, China).

The gene deletion mutant ΔcatB derived from PXO99A was constructed by the homologous recombination as described previously by using the suicide vector pK18mobSacB [44]. The vector pMDcatBl with the left fragment and the vector pMDcatBr with the right fragment were digested with corresponding restriction enzymes and ligated to pK18-mobsacB. A gentamicin resistance gene (Gm r) at 855 bp was then inserted into the intermediate region between left and right fragment carried by pK18mobsacB, resulting in plasmids pKcatB, and then introduced into PXO99A by electroporation. The deletion mutants were screened on PSA plates containing gentamicin and 10 % sucrose. For the complementation experiment, the vector pMDcatB with the catB gene including ribosome binding site was digested by enzymes and cloned into pBBR1MCS-4, generating pBBR-catB, and then transferred into ∆catB by electroporation and screened on PSA plates containing ampicillin.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A